A detailed history of Financial Management Professionals, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 36 shares of REGN stock, worth $25,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Previous 36 -0.0%
Holding current value
$25,266
Previous $38,000 -0.0%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$883.2 - $1071.19 $72,422 - $87,837
-82 Reduced 69.49%
36 $38,000
Q1 2024

Apr 16, 2024

SELL
$902.69 - $993.35 $4,513 - $4,966
-5 Reduced 4.07%
118 $114,000
Q4 2023

Jan 12, 2024

SELL
$775.18 - $881.7 $1,550 - $1,763
-2 Reduced 1.6%
123 $108,000
Q3 2023

Oct 13, 2023

BUY
$692.45 - $844.37 $5,539 - $6,754
8 Added 6.84%
125 $103,000
Q2 2023

Jul 10, 2023

BUY
$700.03 - $830.35 $700 - $830
1 Added 0.86%
117 $84,000
Q1 2023

Apr 13, 2023

BUY
$680.49 - $826.97 $57,841 - $70,292
85 Added 274.19%
116 $95,000
Q3 2022

Oct 27, 2022

BUY
$573.97 - $724.32 $9,757 - $12,313
17 Added 121.43%
31 $21,000
Q1 2022

Apr 27, 2022

BUY
$595.12 - $698.43 $595 - $698
1 Added 7.69%
14 $10,000
Q2 2021

Aug 05, 2021

BUY
$472.8 - $558.54 $3,782 - $4,468
8 Added 160.0%
13 $7,000
Q1 2021

Apr 26, 2021

SELL
$446.73 - $548.2 $446 - $548
-1 Reduced 16.67%
5 $2,000
Q4 2020

Feb 03, 2021

BUY
$478.3 - $607.98 $1,434 - $1,823
3 Added 100.0%
6 $3,000
Q2 2020

Jul 21, 2020

BUY
$493.32 - $643.92 $1,479 - $1,931
3 New
3 $2,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.